Overexpression of kynurenic acid in stroke: An endogenous neuroprotector?
- 1 May 2017
- journal article
- Published by Elsevier in Annals of Anatomy - Anatomischer Anzeiger
- Vol. 211, 33-38
Abstract
No abstract availableKeywords
Funding Information
- European Union FP7 Collaborative Grant TargetBraIn (279017)
This publication has 22 references indexed in Scilit:
- Involvement of the kynurenine pathway in the pathogenesis of Parkinson’s diseaseProgress in Neurobiology, 2017
- Changing the Face of Kynurenines and Neurotoxicity: Therapeutic ConsiderationsInternational Journal of Molecular Sciences, 2015
- Surgery-Related Thrombosis Critically Affects the Brain Infarct Volume in Mice Following Transient Middle Cerebral Artery OcclusionPLOS ONE, 2013
- Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemiaEuropean Journal of Pharmacology, 2011
- The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairmentJournal of Neuroinflammation, 2011
- Endogenous Kynurenine Aminotransferases Inhibitor is Proposed to Act as “Glia Depressing Factor” (GDF)International Journal of Tryptophan Research, 2010
- Characterization of the Kynurenine Pathway in Human NeuronsThe Journal of Neuroscience, 2007
- Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neuronsGlia, 2004
- Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protectionJournal of Neurochemistry, 2001
- Enhanced Expression of Iba1, Ionized Calcium-Binding Adapter Molecule 1, After Transient Focal Cerebral Ischemia In Rat BrainStroke, 2001